Novartis AG is looking at ways to propose price cuts to US President Donald Trump by the end of the month, Chief Executive Officer Vas Narasimhan told Neue Zuercher Zeitung in an interview on Saturday.
“We’re working with the government to find constructive solutions so Americans pay less for their medicines,” Narasimhan said, adding that the company was also working to eliminate the price gap between the US and other industrialized countries.